Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 3, 2012, Pages 328-336

  Martínez Gutierrez, Fidel ^a,b,c   Thi, Emily P ^a   Silverman, Judith M ^a   de Oliveira, Carolina Camargo ^a   Svensson, Sarah L ^a   Hoek, Amanda Vanden ^a,d   Sánchez, Elpidio Morales ^b   Reiner, Neil E ^a   Gaynor, Erin C ^a   Pryzdial, Edward L G ^a,d   Conway, Edward M ^a,d   Orrantia, Erasmo ^c   Ruiz, Facundo ^b   Av Gay, Yossef ^a   Bach, Horacio ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c Centro de Investigaciones de Materiales Avanzados   (Mexico)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antibacterial activity; Clinical isolates; Coagulation effect; Immunological response; Silver nanoparticles

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC-RESISTANT BACTERIA; BIOMEDICAL APPLICATIONS; BIOMEDICAL DEVICES; CLINICAL ISOLATES; CYTOTOXIC; CYTOTOXIC EFFECTS; CYTOTOXICITY EFFECTS; GALLIC ACIDS; HARMFUL EFFECTS; IMMUNOLOGICAL RESPONSE; IN-VITRO; IN-VIVO; INFLAMMATORY CYTOKINES; INFLAMMATORY RESPONSE; INHIBITORY EFFECT; MEDICAL DEVICES; SILVER NANOPARTICLES; TOXIC EFFECT;

ANTIBIOTICS; BACTERIA; COAGULATION; CYTOTOXICITY; INTENSIVE CARE UNITS; MACROPHAGES; MEDICAL APPLICATIONS; NANOPARTICLES;

SILVER;

INTERLEUKIN 10; INTERLEUKIN 6; SILVER NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD CLOTTING; CYTOTOXICITY; FOOD POISONING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; INTENSIVE CARE; MACROPHAGE; MEDICAL DEVICE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN EXPRESSION;

ANTI-BACTERIAL AGENTS; BACTERIA; BLOOD COAGULATION; CELL DEATH; CELL LINE; CYTOKINES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIGHT; MACROPHAGES; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; PARTICLE SIZE; SCATTERING, RADIATION; SILVER;

EID: 84858617840     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.06.014     Document Type: Article

References (38)

1. Kohl Y., Kaiser C., Bost W., Stracke F., Fournelle M., Wischke C., et al. Preparation and biological evaluation of multifunctional PLGA nanoparticles designed for photoacoustic imaging. Nanomedicine 2011, 7:228-237.
2. Meng H., Liong M., Xia T., Li Z., Ji Z., Zink J.I., et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell Line. ACS Nano 2010, 4:4539-4550.
3. Godin B., Sakamoto J.H., Serda R.E., Grattoni A., Bouamrani A., Ferrari M., et al. Emerging applications of nanomedicine for the diagnostic and treatment of cardiovascular diseases. Trends Pharmacol Sci 2010, 31:199-205.
4. Tian J., Wong K.K., Ho C.M., Lok C.N., Yu W.Y., Che C.M., et al. Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem 2007, 2:129-136.
5. Rangari V.K., Mohammad G.M., Jeelani S., Hundley A., Vig K., Singh S.R., et al. Synthesis of Ag/CNT hybrid nanoparticles and fabrication of their nylon-6 polymer nanocomposite fibers for antimicrobial applications. Nanotechnology 2010, 21:095102.
6. Martinez-Gutierrez F., Olive P.L., Banuelos A., Orrantia E., Nino N., Morales Sanchez E., et al. Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomedicine 2010, 6:681-688.
7. Lok C.N., Ho C.M., Chen R., He Q.Y., Yu W.Y., Sun H., et al. Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem 2007, 12:527-534.
8. Morones J.R., Elechiguerra J.L., Camacho A., Holt K., Kouri J.B., Ramirez J.T., et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
9. Lewinsky N., Colvin V., Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4:26-49.
10. Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005, 88:412-419.
11. Rushton E.K., Jiang J., Leonard S.S., Eberly S., Castranova V., Biswas P., et al. Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A 2010, 73:445-461.
12. Feng Q.L., Wu J., Chen G.Q., Cui F.Z., Kim T.N., Kim J. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000, 53:662-668.
13. Matsumura Y., Yoshikata K., Kunisaki S., Tsuchido T. Mode of bactericidal action of silver zeolite and its comparison with that silver nitrate. Appl Environ Microbiol 2003, 69:4278-4281.
14. Sondi I., Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 2004, 275:177-182.
15. Bell R.A., Kramer J.R. Structural chemistry and geochemistry of silver-sulfur compound: critical review. Environ Toxicol Chem 1999, 18:9-22.
16. Di Bernardo P., Dolcetti G., Portanova R., Tolazzi M., Tomat G. Thermodynamic and spectroscopic studies on silver(I) complex formation with phosphorous multidentate ligands in dimethyl sulfoxide. Inorg Chem 1990, 29:2859-2862.
17. Chang C. The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 2010, 34:J234-246.
18. Kang J.L., Moon C., Lee H.S., Lee H.W., Park E.M., Kim H.S., et al. Comparison of the biological activity between ultrafine and fine titanium dioxide particles in RAW 264.7 cells associated with oxidative stress. J Toxicol Environ Health A 2008, 71:478-485.
19. Hsin Y.H., Chen C.F., Huang S., Shih T.S., Lai P.S., Chueh P.J. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 2008, 179:130-139.
20. Martínez-Castañón G.A., Niño-Martínez N., Martínez-Gutierrez F., Martínez-Mendoza J.R., Ruiz F. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanopart Res 2008, 10:1343-1348.
21. Korlath J.A., Osterholm M.T., Judy L.A., Forfang J.C., Robinson R.A. A point-source outbreak of campylobacteriosis associated with consumption of raw milk. J Infect Dis 1985, 152:592-596.
22. Clinical and Laboratory Standards Institute CLSI, antimicrobial susceptibility testing standards M02-A10 and M07-A8 http://www.clsi.org/source/orders/free/m07-a8.pdf.
23. Pick N., Cameron S., Arad D., Av-Gay Y. Screening of compounds toxicity against human monocytic cell line-THP-1 by flow cytometry. Biol Proced Online 2004, 6:220-225.
24. Ho J., Tambyah P.A., Paterson D.L. Multiresistant Gram-negative infections: a global perspective. Curr Op Infect Dis 2010, 23:546-553.
25. Smith D.L., Harris A.D., Johnson J.A., Silbergeld E.K., Morris J.G. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc Nat Acad Sci 2002, 99:5752-5754.
26. Hoffman L.R., D'Argenio D.A., MacCoss M.J., Zhang Z., Jones R.A., Miller S.I. Aminoglucoside antibiotics induce bacterial biofilm formation. Nature 2005, 436:1171-1175.
27. Bradford P.A. Extended-spectrum β-lactamases in the 21st century; characterization, epidemiology and detection of this importance resistance threat. Clin Microbiol Rev 2001, 14:939-951.
28. CLSI Performance Standards for Antimicrobial Susceptibility Testing. Twentieth Informational Supplement. CLSI document M100-S20 2010, Clinical and Laboratory Standards Institute, Wayne, PA.
29. Fayaz A.M., Balaji K., Girilal M., Yadav R., Kalaichelvan P.T., Venketesan R., et al. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria. Nanomed Nanotechnol Biol Med 2010, 6:103-109.
30. CLSI Performance Standards for Antimicrobial Susceptibility Testing. Twentieth Informational Supplement. CLSI document M100-S20 2010, Clinical and Laboratory Standards Institute, Wayne, PA.
31. Yen H.J., Hsu S.H., Tsai C.L. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 2009, 5:1553-1561.
32. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol in Vitro 2005, 19:975-983.
33. Bregoli L., Chiarini F., Gambarelli A., Sighinolfi G., Gatti A.M., Santi P., et al. Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. Toxicol 2009, 262:121-129.
34. 2B receptor-mediated posttranscriptional mechanism. J Immunol 2005, 175:8260-8270.
35. Wu Y., Qiu H., Zeng Y., You X., Deng Z., Yu M., et al. Mycoplasma genitalium lipoproteins induce human monocytic cell expression of proinflammatory cytokines and apoptosis by activating nuclear factor κB. Mediators Inflamm 2008, 2008:195427.
36. Nair S., Ramaswamy P.A., Ghosh S., Joshi D.C., Pathak N., Siddiqui I., et al. The PPE18 of Mycobacterium tuberculosis induction in macrophage interacts with TLR2 and activates IL-10. J Immunol 2009, 183:6269-6281.
37. Johnston M.J.G., Wang A., Catarino M.E.D., Ball L., Phan V.C., MacDonald J.A., et al. Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice. Infect Immun 2010, 78:1364-1375.
38. Vogler E.A., Siedlecki C.A. Contact activation of blood plasma coagulation. Biomaterials 2009, 30:1857-1869.